Our derivatives and structured products team advises investment funds and their managers, investment banks, commodity brokers and traders and other market participants on the full range of derivatives transactions and structured products, together with associated regulatory matters.
Clients come to us because of our market knowledge, deal sophistication and skill working with complex derivatives issues as well as our ability to structure novel products and transactions to meet their needs. This includes supporting clients in major financial centres covering over-the-counter (OTC), exchange traded and derivatives-based securities, as well as repurchase and securities lending agreements. We work with both providers and end users of derivative products across all major markets across the globe, and are supported by our colleagues in financial services regulation, litigation and tax.
Our main areas of focus include:
-
OTC products, including commodity, credit, currency/FX equity, fund and interest rate derivatives, as well as structured products and insurance related products and structures.
-
Highly structured financing transactions including margin loans, total return swap facilities and strategic equity transactions (including funded and synthetic products).
-
Securities financing transactions, repo, structured repo and stock lending facilities, over both liquid and illiquid assets.
-
Negotiating futures, commodity trading agreements, prime brokerage, clearing and other trading facilities as well as related custody and collateral agreements.
-
Advising on issues related to distressed investments, credit and succession events and settlement questions regarding credit default swaps.
-
Analysing the liquidity, credit, insolvency, netting and regulatory risks.
-
Advising on compliance with laws and regulations relating to the derivatives and futures industry, evolving trading infrastructure and litigation matters, including EMIR, SFTR and Dodd Frank compliance.